Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

KalVista Pharmaceuticals (KALV) Shares Outstanding (Diluted Average): 2020-2024

Historic Shares Outstanding (Diluted Average) for KalVista Pharmaceuticals (KALV) over the last 2 years, with Apr 2024 value amounting to $36.8 million.

  • KalVista Pharmaceuticals' Shares Outstanding (Diluted Average) rose 35.09% to $46.7 million in Q4 2024 from the same period last year, while for Oct 2024 it was $46.7 million, marking a year-over-year increase of 35.09%. This contributed to the annual value of $36.8 million for FY2024, which is N/A change from last year.
  • Per KalVista Pharmaceuticals' latest filing, its Shares Outstanding (Diluted Average) stood at $36.8 million for FY2024, which was up 107.26% from $17.7 million recorded in FY2020.
  • KalVista Pharmaceuticals' Shares Outstanding (Diluted Average)'s 5-year high stood at $36.8 million during FY2024, with a 5-year trough of $17.7 million in FY2020.
  • For the 1-year period, KalVista Pharmaceuticals' Shares Outstanding (Diluted Average) averaged around $36.8 million, with its median value being $36.8 million (2024).